Back20/20 Biolabs Common Stock Overview

20/20 Biolabs Common Stock Current Cash

Latest current cash for AIDX: $4.2M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4.22M

Peer average

Loading

20/20 Biolabs Common Stock Current Cash History

Loading

20/20 Biolabs Common Stock vs. peers: Current Cash Comparison

Loading

20/20 Biolabs Common Stock Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

20/20 Biolabs Common Stock (AIDX) FAQ

The latest current cash for AIDX is $4.2M as of March 2026. Investors often review this figure alongside 20/20 Biolabs Common Stock's historical trend and sector peers before judging valuation or financial health.

A current cash figure of $4.2M for AIDX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting AIDX's current cash ($4.2M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.